<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chiola S</submitter><funding>Alan B. Slifka Foundation</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>Whitehall Foundation</funding><funding>NIMH NIH HHS</funding><funding>Brain Research Foundation</funding><funding>Brain and Behavior Research Foundation</funding><funding>NINDS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Mental Health</funding><pagination>4670-4686</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8349370</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(9)</volume><pubmed_abstract>Genetic abnormalities in synaptic proteins are common in individuals with autism; however, our understanding of the cellular and molecular mechanisms disrupted by these abnormalities is limited. SHANK3 is a postsynaptic scaffolding protein of excitatory synapses that has been found mutated or deleted in most patients with 22q13 deletion syndrome and about 2% of individuals with idiopathic autism and intellectual disability. Here, we generated CRISPR/Cas9-engineered human pluripotent stem cells (PSCs) with complete hemizygous SHANK3 deletion (SHANK3&lt;sup>+/-&lt;/sup>), which is the most common genetic abnormality in patients, and investigated the synaptic and morphological properties of SHANK3-deficient PSC-derived cortical neurons engrafted in the mouse prefrontal cortex. We show that human PS</pubmed_abstract><journal>Molecular psychiatry</journal><pubmed_title>Defective AMPA-mediated synaptic transmission and morphology in human neurons with hemizygous SHANK3 deletion engrafted in mouse prefrontal cortex.</pubmed_title><pmcid>PMC8349370</pmcid><funding_grant_id>NS104963-01A1</funding_grant_id><funding_grant_id>R01 MH113670</funding_grant_id><funding_grant_id>R21 NS104963</funding_grant_id><funding_grant_id>1R01MH113670 - 01A1</funding_grant_id><pubmed_authors>Chiola S</pubmed_authors><pubmed_authors>Lazarenko RM</pubmed_authors><pubmed_authors>Shcheglovitov A</pubmed_authors><pubmed_authors>Napan KL</pubmed_authors><pubmed_authors>Cui J</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Armstrong CJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defective AMPA-mediated synaptic transmission and morphology in human neurons with hemizygous SHANK3 deletion engrafted in mouse prefrontal cortex.</name><description>Genetic abnormalities in synaptic proteins are common in individuals with autism; however, our understanding of the cellular and molecular mechanisms disrupted by these abnormalities is limited. SHANK3 is a postsynaptic scaffolding protein of excitatory synapses that has been found mutated or deleted in most patients with 22q13 deletion syndrome and about 2% of individuals with idiopathic autism and intellectual disability. Here, we generated CRISPR/Cas9-engineered human pluripotent stem cells (PSCs) with complete hemizygous SHANK3 deletion (SHANK3&lt;sup>+/-&lt;/sup>), which is the most common genetic abnormality in patients, and investigated the synaptic and morphological properties of SHANK3-deficient PSC-derived cortical neurons engrafted in the mouse prefrontal cortex. We show that human PS</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-19T06:41:26.483Z</modification><creation>2022-02-11T13:11:01.801Z</creation></dates><accession>S-EPMC8349370</accession><cross_references><pubmed>33558651</pubmed><doi>10.1038/s41380-021-01023-2</doi></cross_references></HashMap>